Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Amryt Pharma Plc ADR
(NQ:
AMYT
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Apr 11, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Amryt Pharma Plc ADR
< Previous
1
2
3
Next >
Top 5 Health Care Stocks That Are Ticking Portfolio Bombs
March 14, 2023
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 18, 2023
January 18, 2023
Via
Benzinga
Why Shares of Amryt Pharma Jumped This Week
January 12, 2023
A takeover bid by an Italian pharmaceutical and healthcare company boosted Amryt's shares.
Via
The Motley Fool
Recap: Amryt Pharma Q3 Earnings
November 03, 2022
Amryt Pharma (NASDAQ:AMYT) reported its Q3 earnings results on Thursday, November 3, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Filsuvez's European Approval Adds Growth Driver For Amryt Pharma
June 24, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 10, 2023
January 10, 2023
Via
Benzinga
Recap: Amryt Pharma Q1 Earnings
May 04, 2022
Amryt Pharma (NASDAQ:AMYT) reported its Q1 earnings results on Wednesday, May 4, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Amryt Shares Trading Higher As EMA Endorses Approval Of Filsuvez In Genetic Skin Disease
April 22, 2022
Via
Benzinga
S&P 500 Gains 0.6%; Albireo Pharma Shares Spike Higher
January 09, 2023
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 200 points on Monday.
Via
Benzinga
Why Cutera Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Monday's Mid-Day Session
January 09, 2023
Gainers CinCor Pharma, Inc. (NASDAQ: CINC) shares jumped 137% to $27.93 after AstraZeneca announced it will acquire the company for $26 per share in cash.
Via
Benzinga
Amryt Posts Long-Term Safety, Efficacy Mycapssa Data In Acromegaly Patients
April 13, 2022
Amryt Pharma Plc (NASDAQ: AMYT) has
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
January 09, 2023
Via
Benzinga
Nasdaq Surges Over 200 Points; Crude Oil Rises 2%
January 09, 2023
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 200 points on Monday.
Via
Benzinga
Tesla, Zillow, Albireo Pharma And Some Other Big Stocks Moving Higher On Monday
January 09, 2023
U.S. stocks traded higher, with the Dow Jones gaining more than 150 points on Monday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
US Stocks Open Higher; Dow Rises 150 Points
January 09, 2023
U.S. stocks traded higher this morning, with the Dow Jones gaining around 150 points on Monday.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 9, 2023
January 09, 2023
Via
Benzinga
Adobe To Rally 25%? Here Are 10 Other Analyst Forecasts For Monday
January 09, 2023
Via
Benzinga
Italian Privately Held Chiesi Farmaceutici To Acquire Amryt Pharma For $1.25B
January 09, 2023
Italian family-controlled global pharmaceutical company Chiesi Farmaceutici S.p.A. has agreed to acquire Amryt Pharma Plc (NASDAQ: AMYT) for an implied value of $1.25 billion in upfront consideration.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
January 09, 2023
Via
Benzinga
Why CinCor Pharma Shares Are Trading Higher By 140%; Here Are 20 Stocks Moving Premarket
January 09, 2023
Gainers CinCor Pharma, Inc. (NASDAQ: CINC) rose 140.2% to $28.30 in pre-market trading after AstraZeneca announced plans to buy the company for up to $1.8 billion.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
January 09, 2023
We're starting off the week with a look at the biggest pre-market stock movers traders need to know about on Monday morning!
Via
InvestorPlace
Important Biotech Catalysts For September 8, 2022 - End Of The Day Summary
September 08, 2022
Via
Benzinga
Amryt Secures UK Regulatory Nod And Orphan Disease Status For Skin Disorder Candidate
September 08, 2022
The Medical Healthcare & Products Regulatory Agency (MHRA) has granted Marketing Authorisation Approval (MAA) and Orphan Disease Designation (ODD) for Amryt’s (NASDAQ: AMYT) lead candidate Filsuvez for...
Via
Benzinga
The Daily Biotech Pulse: Much Awaited FDA Nod For Novavax's COVID-19 Shot, DSMB Suggests ContraFect To Stop Antimicrobial-Resistant Infection Study, CytomX Restructures
July 14, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
July 14, 2022
Via
Benzinga
Amryt Shares Shoot Higher As FDA Grants Orphan Drug Status To Carcinoid Tumor Candidate
July 14, 2022
The US Food and Drug Administration (FDA) has granted Orphan Drug Designation to Amryt’s (NASDAQ: AMYT) lead drug Mycapssa for the treatment of carcinoid syndrome. Carcinoid syndrome (CS) is the most...
Via
Benzinga
The Daily Biotech Pulse: F-Star Therapeutics Buyout, Orphan Drug Tag For VBI's Brain Cancer Vaccine, Xenon's Epilepsy Candidate Shows Promise
June 23, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
June 23, 2022
Via
Benzinga
55 Biggest Movers From Friday
April 25, 2022
Gainers Vallon Pharmaceuticals, Inc. (NASDAQ: VLON) shares jumped 100.9% to close at $2.27 on Friday. Vallon Pharmaceuticals engaged Ladenburg Thalmann & Co Inc to evaluate...
Via
Benzinga
Amryt Pharma's Q4 FY21 Sales, FY22 Guidance Shy Of Street Consensus
March 09, 2022
Amryt Pharma Plc's (NASDAQ: AMYT) Q4 FY21 sales increased 29% Y/Y to $54.8 million, missing the consensus of $56.81 million. The growth was driven by metreleptin...
Via
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.